Filing Details
- Accession Number:
- 0001388410-19-000152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 17:12:15
- Reporting Period:
- 2019-07-01
- Accepted Time:
- 2019-11-19 17:12:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1388410 | Parallax Health Sciences Inc. | PRLX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1275657 | R Paul Arena | 1327 Ocean Ave Suite M Santa Monica CA 90401 | Ceo, President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock (Restricted) | Acquisiton | 2019-07-01 | 2,375,000 | $0.00 | 7,375,000 | No | 5 | A | Direct | |
Common Stock (Restricted) | Acquisiton | 2019-09-30 | 1,600,000 | $0.06 | 8,975,000 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | A | Direct | |
No | 5 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | WARRANTS | Acquisiton | 2019-09-30 | 1,600,000 | $0.00 | 1,600,000 | $0.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,645,000 | 2019-09-30 | 2022-09-30 | No | 5 | A | Direct |
Footnotes
- Granted pursuant to Employment Agreement dated July 1, 2017.
- Total restricted stock grant 10,000,000 common shares, of which a total of 7,500,000 have vested, and 2,500,000 will vest upon positive earnings.
- Issued in connection with a Securities Purchase Agreement dated September 30, 2019, for proceeds in the amount of $100,000, paid by way of reduction in accrued compensation.
- Warrants granted in connection with Securities Purchase Agreement dated September 30, 2019.